Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany

E. Smits*, F. Andreotti, E. Houben, H.J.G.M. Crijns, S. Haas, G. Spentzouris, T. Schink, R. Gini, C. Bartolini, F. Penning-van Beest, R. Herings

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)199-209
Number of pages11
JournalDrugs-Real World Outcomes
Volume9
Issue number2
Early online date6 Jan 2022
DOIs
Publication statusPublished - Jun 2022

Keywords

  • DOSING FREQUENCY
  • MEDICATION ADHERENCE
  • STROKE RISK
  • WARFARIN
  • SAFETY
  • EFFICACY
  • RIVAROXABAN
  • DABIGATRAN
  • REGIMENS
  • THERAPY

Cite this